Bookmark
Forward
Changes in clinical laboratory operations and biosafety measures to mitigate biohazard risks during the COVID-19 pandemic.
Kay Weng Choy
The Lancet. Microbe 2020 Nov
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Kay Weng Choy.
Changes in clinical laboratory operations and biosafety measures to mitigate biohazard risks during the COVID-19 pandemic.
The Lancet. Microbe.
2020 Nov;1(7):e273-e274
Mesh Tags
COVID-19
Containment of Biohazards
Hazardous Substances
Humans
Laboratories, Clinical
Pandemics
Substances
Hazardous Substances
PMID: 33521724
View Full Text